SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-076953
Filing Date
2023-06-30
Accepted
2023-06-30 14:04:11
Documents
14
Period of Report
2023-06-30
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2320239d2_8k.htm   iXBRL 8-K 27868
2 EXHIBIT 16.1 tm2320239d2_ex16-1.htm EX-16.1 3796
6 GRAPHIC tm2320239d2_ex16-1img001.jpg GRAPHIC 2282
  Complete submission text file 0001104659-23-076953.txt   208664

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acur-20230630.xsd EX-101.SCH 3233
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE acur-20230630_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acur-20230630_pre.xml EX-101.PRE 22363
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2320239d2_8k_htm.xml XML 3500
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10113 | Film No.: 231061036
SIC: 2834 Pharmaceutical Preparations